{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:02:48Z","timestamp":1775898168341,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jdin.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:59:47Z","timestamp":1636743587000},"page":"6-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Efficacy of rituximab in pediatric pemphigus: A literature review"],"prefix":"10.1016","volume":"6","author":[{"given":"Meera H.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin M.","family":"Brumfiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7656-5567","authenticated-orcid":false,"given":"Nicholas","family":"Bohrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda F.","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdin.2021.10.002_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000287254","article-title":"Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature","volume":"221","author":"Fuertes","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jdin.2021.10.002_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pde.13926","article-title":"Rituximab therapy in pediatric pemphigus patients: a retrospective analysis of five Turkish patients and review of the literature","volume":"36","author":"Bilgic-Temel","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1525-1470.2007.00369.x","article-title":"Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment","volume":"24","author":"Connelly","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib4","first-page":"288","article-title":"Resolution of a case of pediatric pemphigus vulgaris treated with rituximab","volume":"22","author":"Didona","year":"2014","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jdin.2021.10.002_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4103\/0378-6323.100587","article-title":"Childhood pemphigus vulgaris successfully treated with rituximab","volume":"78","author":"Kanwar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jdin.2021.10.002_bib6","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/j.1468-3083.2011.04391.x","article-title":"Efficacy and safety of rituximab treatment in Indian pemphigus patients","volume":"27","author":"Kanwar","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdin.2021.10.002_bib7","first-page":"1","article-title":"Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients","author":"Kianfar","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jdin.2021.10.002_bib8","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/pde.12744","article-title":"Rituximab therapy for childhood pemphigus vulgaris","volume":"33","author":"Kincaid","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1525-1470.2005.00118.x","article-title":"Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab)","volume":"22","author":"Kong","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/pde.12684","article-title":"Retrospective study on autoimmune blistering disease in paediatric patients","volume":"32","author":"Kong","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.5070\/D3236035373","article-title":"Rituximab in the management of juvenile pemphigus foliaceus","volume":"23","author":"Loh","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdin.2021.10.002_bib12","first-page":"335","article-title":"Rituximab therapy in severe juvenile pemphigus vulgaris","volume":"80","author":"Mamelak","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.jdin.2021.10.002_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2011.12.019","article-title":"Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up","volume":"67","author":"Reguiai","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib14","first-page":"47","article-title":"Modified rheumatoid arthritis protocol for rituximab in pemphigus: a retrospective case series","volume":"13","author":"Sakhiya","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.2005.06740.x","article-title":"Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab","volume":"153","author":"Schmidt","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2014.05.071","article-title":"Successful use of rituximab in the treatment of childhood and juvenile pemphigus","volume":"71","author":"Vinay","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2021.10.002_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/ijr.12.7","article-title":"Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis?","volume":"7","author":"Chen","year":"2012","journal-title":"Int J Clin Rheumtol"},{"key":"10.1016\/j.jdin.2021.10.002_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12969-019-0365-y","article-title":"Rituximab-associated hypogammaglobulinemia in pediatric patients with autoimmune diseases","volume":"17","author":"Khojah","year":"2019","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328721000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328721000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:00Z","timestamp":1762981200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328721000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":18,"alternative-id":["S2666328721000791"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2021.10.002","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of rituximab in pediatric pemphigus: A literature review","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}